EP1599184A4 - Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same - Google Patents

Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same

Info

Publication number
EP1599184A4
EP1599184A4 EP03790479A EP03790479A EP1599184A4 EP 1599184 A4 EP1599184 A4 EP 1599184A4 EP 03790479 A EP03790479 A EP 03790479A EP 03790479 A EP03790479 A EP 03790479A EP 1599184 A4 EP1599184 A4 EP 1599184A4
Authority
EP
European Patent Office
Prior art keywords
hydrofluorocarbon
perfluorocarbon
formulations
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03790479A
Other languages
German (de)
French (fr)
Other versions
EP1599184A1 (en
Inventor
Stephen Pham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chrysalis Technologies Inc
Original Assignee
Chrysalis Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chrysalis Technologies Inc filed Critical Chrysalis Technologies Inc
Publication of EP1599184A1 publication Critical patent/EP1599184A1/en
Publication of EP1599184A4 publication Critical patent/EP1599184A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A61M11/044—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical with electrodes immersed in the liquid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/36—General characteristics of the apparatus related to heating or cooling
    • A61M2205/3653—General characteristics of the apparatus related to heating or cooling by Joule effect, i.e. electric resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated
EP03790479A 2003-02-04 2003-12-15 Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same Withdrawn EP1599184A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44462103P 2003-02-04 2003-02-04
US444621P 2003-02-04
PCT/US2003/039561 WO2004071488A1 (en) 2003-02-04 2003-12-15 Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same

Publications (2)

Publication Number Publication Date
EP1599184A1 EP1599184A1 (en) 2005-11-30
EP1599184A4 true EP1599184A4 (en) 2009-06-24

Family

ID=32869293

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03790479A Withdrawn EP1599184A4 (en) 2003-02-04 2003-12-15 Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same

Country Status (4)

Country Link
EP (1) EP1599184A4 (en)
JP (1) JP2006516545A (en)
AU (1) AU2003293528A1 (en)
WO (1) WO2004071488A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279451B2 (en) * 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
CA2563544A1 (en) * 2004-04-19 2005-10-27 Centre National De La Recherche Scientifique (C.N.R.S.) Lung surfactant supplements
ES2622372T3 (en) 2012-11-09 2017-07-06 Scidose Llc Enema composition for treatment of ulcerative colitis that has long-term stability
WO2016191700A1 (en) * 2015-05-27 2016-12-01 Nuvox Pharma Llc Treatment of acute complications of sickle cell disease
JP7216590B2 (en) * 2019-03-26 2023-02-01 ユニマテック株式会社 Perfluoro group-containing compound emulsion

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019300A1 (en) * 1991-05-01 1992-11-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Perfluorocarbon associated gas exchange
WO1996019198A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations
WO1996019197A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol formulations of peptides and proteins
WO1996029985A1 (en) * 1995-03-31 1996-10-03 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
WO2000030608A1 (en) * 1998-11-25 2000-06-02 Chiesi Farmaceutici S.P.A. Pressurised metered dose inhalers (mdi)
FR2806077A1 (en) * 2000-03-07 2001-09-14 Solvay Production of purified hydrofluoroalkane for use as propulsive gas in medical aerosols, comprises subjecting hydrofluoroalkane containing organic impurities to at least two distillations
WO2001095881A1 (en) * 2000-06-16 2001-12-20 Glaxo Group Limited Pharmaceutical anti-inflammatory aerosol formulation
WO2002049616A1 (en) * 2000-12-19 2002-06-27 Astrazeneca Ab Pharmaceutical aerosol formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000215A1 (en) * 1998-06-29 2000-01-06 Inhale Therapeutic Systems, Inc. Particulate delivery systems and methods of use

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US6242472B1 (en) * 1989-08-28 2001-06-05 Alliance Pharmaceutical Corp. Methods for the pulmonary delivery of biological agents
WO1992019300A1 (en) * 1991-05-01 1992-11-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Perfluorocarbon associated gas exchange
WO1996019198A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations
WO1996019197A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol formulations of peptides and proteins
WO1996029985A1 (en) * 1995-03-31 1996-10-03 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
WO2000030608A1 (en) * 1998-11-25 2000-06-02 Chiesi Farmaceutici S.P.A. Pressurised metered dose inhalers (mdi)
FR2806077A1 (en) * 2000-03-07 2001-09-14 Solvay Production of purified hydrofluoroalkane for use as propulsive gas in medical aerosols, comprises subjecting hydrofluoroalkane containing organic impurities to at least two distillations
WO2001095881A1 (en) * 2000-06-16 2001-12-20 Glaxo Group Limited Pharmaceutical anti-inflammatory aerosol formulation
WO2002049616A1 (en) * 2000-12-19 2002-06-27 Astrazeneca Ab Pharmaceutical aerosol formulation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
M. E. AULTON: "Pharmaceutics: The Science of Dosage Form Design.", 2002, CHURCHILL LIVINGSTONE, article KEVIN TAYLOR: "Pulmonary drug delivery", pages: 473 - 487 *
See also references of WO2004071488A1 *

Also Published As

Publication number Publication date
WO2004071488A1 (en) 2004-08-26
JP2006516545A (en) 2006-07-06
EP1599184A1 (en) 2005-11-30
AU2003293528A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
GB2405748B (en) Field assemblies and methods of making same
AU2003259735A1 (en) Small-mer compositions and methods of use
CA2874604A1 (en) Extended release formulations of opioids and method of use thereof
EP1551376A4 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
IL219406A0 (en) Antiloading compositions and methods of selecting same
IL169648A0 (en) Novel structures and method of preparation
EP1661228A4 (en) Field assemblies and methods of making same
HK1130254A1 (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
AU2003239614A8 (en) Cardiolipin compositions, methods of preparation and use
EP1639086A4 (en) Rna interferases and methods of use thereof
AU2003299441A1 (en) Nf-hev compositions and methods of use
EP1663255A4 (en) Withanamide and withanolide compositions and method of use thereof
AU2003247351A1 (en) Anti-acne compositions and methods of use
EP1633749A4 (en) Deazaflavin compounds and methods of use thereof
EP1625141A4 (en) Grp94-based compositions and methods of use thereof
EP1599184A4 (en) Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
GB2430085B (en) Field assemblies and methods of making same
AU2003297218A1 (en) Npc1l1 (npc3) and methods of use thereof
EP1686990A4 (en) 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
WO2005042707A9 (en) Taspasel 1 and methods of use
AU2003300770A1 (en) Cardiolipin compositions their methods of preparation and use
GB2430810B (en) Field assemblies and methods of making same
GB2429338B (en) Field assemblies and methods of making same
GB2437421B (en) Field assemblies and methods of making same
ZA200503793B (en) Gastrin compositions and formulations, and methods of use and preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050901

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090527

17Q First examination report despatched

Effective date: 20101209

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110420